Recombinant Human Erythropoietin in the Treatment of Acute Ischemic Stroke-Reference-Cited by-同舟云学术

Recombinant Human Erythropoietin in the Treatment of Acute Ischemic Stroke

Published:2009-12 Issue:12 Volume:40 Page:
ISSN:0039-2499
Container-title:Stroke
language:en
Short-container-title:Stroke

Author:

Ehrenreich Hannelore¹,Weissenborn Karin¹,Prange Hilmar¹,Schneider Dietmar¹,Weimar Christian¹,Wartenberg Katja¹,Schellinger Peter D.¹,Bohn Matthias¹,Becker Harald¹,Wegrzyn Martin¹,Jähnig Peter¹,Herrmann Manfred¹,Knauth Michael¹,Bähr Mathias¹,Heide Wolfgang¹,Wagner Armin¹,Schwab Stefan¹,Reichmann Heinz¹,Schwendemann Günther¹,Dengler Reinhard¹,Kastrup Andreas¹,Bartels Claudia¹

Affiliation:

1. From the Division of Clinical Neuroscience (H.E., M.W., C.B.), Max Planck Institute of Experimental Medicine, Göttingen, Germany; Center for Neurological Medicine (K.W., R.D.), Hannover Medical School, Hannover, Germany; the Department of Neurology (H.P., M.B., A.K.), University Medical Center Göttingen, Georg-August-University, Göttingen, Germany; the Department of Neurology (D.S., A.W.), University Hospital of Leipzig, Leipzig, Germany; the Department of Neurology (C.W.), University of Duisburg...

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Advanced and Specialised Nursing,Cardiology and Cardiovascular Medicine,Clinical Neurology

Reference31 articles.

1. 1,026 Experimental treatments in acute stroke

2. Erythropoietin Therapy for Acute Stroke Is Both Safe and Beneficial

3. Emerging biological roles for erythropoietin in the nervous system

4. Recombinant erythropoietin as a neuroprotective treatment: in vitro and in vivo models

5. Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury

Cited by 501 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peptides derived from growth factors: Exploring their diverse impact from antimicrobial properties to neuroprotection;Biomedicine & Pharmacotherapy;2024-07

2. Role of erythropoietin in the treatment of Alzheimer’s disease: the story so far;Annals of Medicine & Surgery;2024-05-01

3. Early Postnatal Administration of Erythropoietin and Its Association with Neurodevelopmental Outcomes and Incidence of Intraventricular Hemorrhage and Hypoxic-Ischemic Encephalopathy: A Four-Week Observational Study;Pediatric Reports;2024-04-28

4. Neuronal nitric oxide synthase required for erythropoietin modulation of heart function in mice;Frontiers in Physiology;2024-04-02

5. Erythropoietin‐derived peptide ARA290 mediates brain tissue protection through the β‐common receptor in mice with cerebral ischemic stroke;CNS Neuroscience & Therapeutics;2024-03